Assessing Bioequivalence of Antiepileptic Drugs: Are the Current Requirements too Permissive?
Purpose: In order to evaluate the permissiveness of current bioequivalence requirements for antiepileptic drugs we investigated how accurate Cmax and AUC0-t of generic antiepileptic drugs approved in Brazil are in comparison to reference products. Methods: Data collected from assessment reports of a...
Main Authors: | Camila F Rediguieri, Jorge L Zeredo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-05-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/21116 |
Similar Items
-
Expert Approaches to the Assessment of Losartan Drugs Bioequivalence
by: D. P. Romodanovsky, et al.
Published: (2020-02-01) -
Current status of the New Antiepileptic drugs in chronic pain.
by: Harpreet Singh Sidhu, et al.
Published: (2016-08-01) -
The pharmacogenetics antiepileptic drugs
by: N. A. Shnayder, et al.
Published: (2008-12-01) -
Peculiarities of approaches to assessing the interchangeability of antiepileptic drugs
by: E. O. Zhuravleva, et al.
Published: (2018-02-01) -
Synchronic requirements and diachronic permissions
by: Broome, J
Published: (2015)